2W5S
Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS.
2W5S の概要
| エントリーDOI | 10.2210/pdb2w5s/pdb |
| 関連するPDBエントリー | 2W5Q 2W5R 2W5T |
| 分子名称 | PROCESSED GLYCEROL PHOSPHATE LIPOTEICHOIC ACID SYNTHASE, MANGANESE (II) ION, ACETATE ION, ... (5 entities in total) |
| 機能のキーワード | transmembrane, cell wall biogenesis/degradation, ltas, membrane, secreted, transferase, cell membrane |
| 由来する生物種 | STAPHYLOCOCCUS AUREUS |
| 細胞内の位置 | Cell membrane; Multi-pass membrane protein (Potential). Processed glycerol phosphate lipoteichoic acid synthase: Secreted (By similarity): Q7A1I3 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 49154.72 |
| 構造登録者 | Lu, D.,Wormann, M.E.,Zhang, X.,Schneewind, O.,Grundling, A.,Freemont, P.S. (登録日: 2008-12-11, 公開日: 2009-02-03, 最終更新日: 2023-12-13) |
| 主引用文献 | Lu, D.,Wormann, M.E.,Zhang, X.,Schneewind, O.,Grundling, A.,Freemont, P.S. Structure-Based Mechanism of Lipoteichoic Acid Synthesis by Staphylococcus Aureus Ltas. Proc.Natl.Acad.Sci.USA, 106:1584-, 2009 Cited by PubMed Abstract: Staphylococcus aureus synthesizes polyglycerol-phosphate lipoteichoic acid (LTA) from phosphatidylglycerol. LtaS, a predicted membrane protein with 5 N-terminal transmembrane helices followed by a large extracellular part (eLtaS), is required for staphylococcal growth and LTA synthesis. Here, we report the first crystal structure of the eLtaS domain at 1.2-A resolution and show that it assumes a sulfatase-like fold with an alpha/beta core and a C-terminal part composed of 4 anti-parallel beta-strands and a long alpha-helix. Overlaying eLtaS with sulfatase structures identified active site residues, which were confirmed by alanine substitution mutagenesis and in vivo enzyme function assays. The cocrystal structure with glycerol-phosphate and the coordination of a Mn(2+) cation allowed us to propose a reaction mechanism, whereby the active site threonine of LtaS functions as nucleophile for phosphatidylglycerol hydrolysis and formation of a covalent threonine-glycerolphosphate intermediate. These results will aid in the development of LtaS-specific inhibitors for S. aureus and many other Gram-positive pathogens. PubMed: 19168632DOI: 10.1073/PNAS.0809020106 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






